Review



dhea treatments  (Avanti Polar)


Bioz Verified Symbol Avanti Polar is a verified supplier
Bioz Manufacturer Symbol Avanti Polar manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Avanti Polar dhea treatments
    Dhea Treatments, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 94/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dhea treatments/product/Avanti Polar
    Average 94 stars, based on 26 article reviews
    dhea treatments - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    treatment with dhea  (MedChemExpress)
    95
    MedChemExpress treatment with dhea
    <t>DHEA</t> inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated <t>with</t> <t>DHEA</t> at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference
    Treatment With Dhea, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/treatment with dhea/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    treatment with dhea - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    dhea treatments  (Avanti Polar)
    94
    Avanti Polar dhea treatments
    <t>DHEA</t> inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated <t>with</t> <t>DHEA</t> at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference
    Dhea Treatments, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dhea treatments/product/Avanti Polar
    Average 94 stars, based on 1 article reviews
    dhea treatments - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    dhea treatment  (TargetMol)
    94
    TargetMol dhea treatment
    <t>DHEA</t> inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated <t>with</t> <t>DHEA</t> at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference
    Dhea Treatment, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dhea treatment/product/TargetMol
    Average 94 stars, based on 1 article reviews
    dhea treatment - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    dhea s treatment  (steraloids inc)
    93
    steraloids inc dhea s treatment
    <t>DHEA</t> inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated <t>with</t> <t>DHEA</t> at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference
    Dhea S Treatment, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dhea s treatment/product/steraloids inc
    Average 93 stars, based on 1 article reviews
    dhea s treatment - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    dhea treatment  (DuPont de Nemours)
    90
    DuPont de Nemours dhea treatment
    <t>DHEA</t> inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated <t>with</t> <t>DHEA</t> at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference
    Dhea Treatment, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dhea treatment/product/DuPont de Nemours
    Average 90 stars, based on 1 article reviews
    dhea treatment - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    DHEA inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated with DHEA at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference

    Journal: Molecular Medicine

    Article Title: Androgens alleviate the depression-like phenotype in female mice by inhibiting AVPR1a in the hippocampal brain region

    doi: 10.1186/s10020-025-01272-9

    Figure Lengend Snippet: DHEA inhibited AVPR1a expression in HT22 cells via AR. A The expression of AVPR1a protein in HT22 cells treated with DHEA at different concentrations (0 µM, 10 µM and 20 µM) for different durations (24 h and 48 h) was detected by western blot. B , C The relative expression of AVPR1a protein ( B ) and mRNA ( C ) in HT22 cells treated with different concentrations (0 µM, 10 µM, and 20 µM) of DHEA for different periods (24 h and 48 h). D The expression of AVPR1a protein in DHEA-treated HT22 cells after antagonist pretreatment was detected by western blot. E , F The relative expression of AR protein ( E ) and mRNA ( F ) in DHEA-treated HT22 cells after antagonist pretreatment. G , H The relative expression of AVPR1a protein ( G ) and mRNA ( H ) in DHEA-treated HT22 cells after antagonist pretreatment. The data are shown as the mean ± SEM. Two-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6B-C and one-way ANOVA followed by Tukey’s post hoc test was used for Fig. 6E-F, G-H, and the experiment was repeated three times independently with similar results. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001, ns indicates no significant difference

    Article Snippet: The female mice were randomly divided into two groups and received treatment with DHEA (30 mg/kg/day, MCE, #HY-14650) or sesame oil (Beyotime, #ST2627) via abdominal subcutaneous injection.

    Techniques: Expressing, Western Blot